Dr. Michael Walsh received his MD, internal medicine and nephrology training at the University of Calgary. He then completed a MSc in Clinical Epidemiology and a research fellowship in lupus and vasculitis at the University of Cambridge followed by a second fellowship and a PhD in Health Research Methodology at McMaster University. He is now an Assistant Professor of Medicine (Nephrology) and Clinical Epidemiology and Biostatistics. His research interests are in systemic autoimmune diseases, particularly ANCA associated vasculitis, chronic kidney disease, and end-stage renal disease with a focus on prospective studies and clinical trials to evaluate risk markers, understand pathophysiology, and develop effective treatment strategies. He is member of several research groups including the European Vasculitis Research Group (EUVAS), the Vasculitis Clinics Research Consortium (VCRC), the Clinical Advances through Research and Information Translation (CLARITY), and the Population Health Research Institute (PHRI). Dr. Walsh is the recipient of numerous research grants and awards and supervises graduate students through the Health Research Methods program.